Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Docetaxel is effective against various cancers but mainly causes neutropenia.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Certain topical drugs can regrow hair in mice.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.